Sage Journals: Discover world-class research

Retricted access

Research article

First published 2011-5

Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study

S Cook, P Vermersch, G Comi [...]

Multiple Sclerosis Journal

Open access

Review article

First published 2020

Expert opinion on the use of cladribine tablets in clinical practice

Per Soelberg Sørensen, Diego Centonze, Gavin Giovannoni [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2024

Cladribine tablets after treatment with natalizumab (CLADRINA) – rationale and design

Peter V. Sguigna, Rehana Z. Hussain, Annette Okai [...]

Therapeutic Advances in Neurological Disorders

Open access

Review article

First published 2025

Cladribine tablets in the new multiple sclerosis era

Fabio Buttari, Ettore Dolcetti, Francesca Romana Rizzo [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2026

Insights into adherence to cladribine tablets in the real world in multiple countries: results from patient support programs

Jiwon Oh, Mavis Ayer, Raed Alroughani [...]

Therapeutic Advances in Neurological Disorders

Open access

Review article

First published 2021

Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice

Peter Rieckmann, Diego Centonze, Gavin Giovannoni [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2019-5

Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study

Gavin Giovannoni, Per Soelberg Sorensen, Stuart Cook [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2021-7

Treatment-emergent adverse events occurring early in the treatment course of cladribine tablets in two phase 3 trials in multiple sclerosis

Jiwon Oh, Bryan Walker, Gavin Giovannoni [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Research article

First published 2018-10

Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study

Gavin Giovannoni, Per Soelberg Sorensen, Stuart Cook [...]

Multiple Sclerosis Journal

Open access

Review article

First published 2021

Vaccination in multiple sclerosis patients treated with highly effective disease-modifying drugs: an overview with consideration of cladribine tablets

Ralf Gold, Gerd Fätkenheuer, Hans-Peter Hartung [...]

Therapeutic Advances in Neurological Disorders

Search results